Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.56 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.56 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.56 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.56 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | ALPG | P10696 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | KDM4A | O75164 | 4/20 | 0.52 |
| ▸ | KDM2A | Q9Y2K7 | 4/20 | 0.52 |
| ▸ | INSR | P06213 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5128472 | 1.00 | CHRM2 (0.56) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL3054036 | 0.98 | CHRM2 (0.55) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL7619893 | 0.98 | CHRM2 (0.55) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL3054039 | 0.98 | CHRM2 (0.55) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL16183107 | 0.98 | CHRM2 (0.55) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL10340880 | 0.98 | CHRM2 (0.55) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL10341023 | 0.98 | CHRM2 (0.55) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL10340879 | 0.98 | CHRM2 (0.55) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL10341093 | 0.98 | CHRM2 (0.55) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL10340951 | 0.98 | CHRM2 (0.55) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3131655-B1 | METHOD FOR THE QUANTIFICATION OF PARASITE EGGS IN FECES | MEP Equine Solutions LLC (US) | 2020-12-02 | — | — | EP | claimed |
| US-10094829-B2 | Method for the quantification of parasite eggs in feces | MEP Equine Solutions LLC (US) | 2018-10-09 | — | — | US | claimed |
| US-9933425-B2 | Method for the quantification of parasite eggs in feces | MEP Equine Solutions LLC (US) | 2018-04-03 | — | — | US | claimed |
| US-20180074055-A1 | METHOD FOR THE QUANTIFICATION OF PARASITE EGGS IN FECES | Parasight System Inc. | 2018-03-15 | — | — | US | claimed |
| US-20150293091-A1 | METHOD FOR THE QUANTIFICATION OF PARASITE EGGS IN FECES | Parasight System Inc. | 2015-10-15 | — | — | US | claimed |
| US-8383415-B2 | Hydrogel composition to enhance fluorescence | DSO NATIONAL LABORATORIES (SG) | 2013-02-26 | — | — | US | claimed |
| EP-4707406-A2 | DETERMINATION OF POLYMORPHISMS USING ISOTHERMAL NUCLEIC ACID AMPLIFICATION | Abbott Diagnostics Scarborough, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-12566186-B2 | Assays for detecting the presence or amount of an anti-drug antibody | GENZYME CORPORATION (US) | 2026-03-03 | — | — | US | disclosed |
| US-20260015656-A1 | DETERMINATION OF POLYMORPHISMS USING ISOTHERMAL NUCLEIC ACID AMPLIFICATION | ABBOTT DIAGNOSTICS SCARBOROUGH INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250263786-A1 | DETERMINATION OF POLYMORPHISMS USING ISOTHERMAL NUCLEIC ACID AMPLIFICATION | ABBOTT DIAGNOSTICS SCARBOROUGH, INC. | 2025-08-21 | — | — | US | disclosed |
| EP-4582812-A2 | ASSAYS FOR DETECTING THE PRESENCE OR AMOUNT OF AN ANTI-DRUG ANTIBODY | Genzyme Corporation (US) | 2025-07-09 | — | — | EP | disclosed |
| EP-4137816-B1 | ASSAYS FOR DETECTING THE PRESENCE OR AMOUNT OF AN ANTI-DRUG ANTIBODY | GENZYME CORP (US) | 2025-03-19 | — | — | EP | disclosed |
| CN-119120674-A | Method and kit for detecting activity of recombinase | 深圳市真迈生物科技有限公司 | 2024-12-13 | — | — | CN | disclosed |
| US-20090004461-A1 | Metal-Enhanced Fluorescence from Plastic Substrates | UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) | 2009-01-01 | — | — | US | disclosed |
| US-20080317768-A1 | BIOCONJUGATED NANOPARTICLES | BOEING COMPANY (US) | 2008-12-25 | — | — | US | disclosed |
| US-20080286880-A1 | Methods and Systems for Nanoparticle Enhancement of Signals | THE PENN STATE RESEARCH FOUNDATION (US) | 2008-11-20 | — | — | US | disclosed |
| US-20070269826-A1 | ANGULAR-DEPENDENT METAL-ENHANCED FLUORESCENCE | UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) | 2007-11-22 | — | — | US | disclosed |
| WO-2007043973-A1 | METHOD OF ENHANCING A FLUORESCENT SIGNAL | DSO NATIONAL LABORATORIES (SG) | 2007-04-19 | — | — | WO | disclosed |
| US-20050202464-A1 | Radiative decay engineering | UNIVERSITY OF MARYLAND, BALTIMORE | 2005-09-15 | — | — | US | disclosed |
| US-20030228682-A1 | Fluorescence sensing | UNIVERSITY OF MARYLAND, BALTIMORE | 2003-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015656-A1 | DETERMINATION OF POLYMORPHISMS USING ISOTHERMAL NUCLEIC ACID AMPLIFICATION | RPA1, RAD54L, RPAP1 | CHRM2 4829/4885CHRM4 4389/4885CHRM5 4698/4885 |
| US-12566186-B2 | Assays for detecting the presence or amount of an anti-drug antibody | ADA, ADAR, HLA-A | CHRM2 2297/4885CHRM4 2256/4885CHRM5 3223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.